Mrv1909 02082019372D 7 6 0 0 0 0 999 V2000 0.0042 0.6138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7181 0.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4321 0.6179 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7139 0.2046 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 -1.4275 0.6220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7186 -0.6220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4321 -0.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 4 1 0 0 0 0 4 5 1 0 0 0 0 2 3 2 0 0 0 0 4 6 1 0 0 0 0 1 2 1 0 0 0 0 4 7 1 0 0 0 0 M CHG 1 4 1 M END > DB04401 > drugbank > C[N+](C)(C)CC=O > InChI=1S/C5H12NO/c1-6(2,3)4-5-7/h5H,4H2,1-3H3/q+1 > SXKNCCSPZDCRFD-UHFFFAOYSA-N > C5H12NO > 102.1549 > 102.091889011 > 1 > 19 > 1.0 > 11.63573187359404 > 1 > 0 > 1 > 0 > trimethyl(2-oxoethyl)azanium > -2.69 > -4.6528000948050785 > -2.17 > 0 > 1 > 0 > 1 > -8.17672175984932 > 17.07 > 41.0609 > 2 > 1 > 9.32e-01 g/l > 11-[(1S,3aS,3bR,4R,9bS,11aS)-1,7-dihydroxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H-cyclopenta[a]phenanthren-4-yl]-N-butyl-N-methylundecanamide > 1 > DB04401 > EXPT00767 > experimental > Betaine aldehyde > Glycine betaine aldehyde $$$$